Chemistry:BRL-15,572

From HandWiki
Revision as of 09:41, 8 February 2024 by HamTop (talk | contribs) (change)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
BRL-15,572
BRL-15572 structure.png
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
ChEMBL
Chemical and physical data
FormulaC25H27ClN2O
Molar mass406.95 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

BRL-15,572 is a drug which acts as a selective antagonist for the serotonin receptor subtype 5-HT1D, with around 60x selectivity over other related receptors. The 5-HT1D receptor has a very similar pharmacology to the closely related 5-HT1B receptor, and most older ligands for these receptors bind to both subtypes with approximately equal affinity, so development of compounds such as BRL-15572 which are able to selectively block the 5-HT1D subtype while leaving 5-HT1B unaffected, have been a significant advance which has helped scientists in researching the function of these serotonin receptor subtypes.[1][2] One function of the 5-HT1D receptor this research has revealed is its role in modulating release of the neurotransmitter glutamate in the brain,[3] as well as functions in regulation of cerebral blood pressure which are important in the pathogenesis of migraine headaches.[4]

References

  1. "SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors". Naunyn-Schmiedeberg's Archives of Pharmacology 356 (3): 312–20. September 1997. doi:10.1007/pl00005056. PMID 9303567. 
  2. "Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors". Naunyn-Schmiedeberg's Archives of Pharmacology 356 (3): 321–7. September 1997. doi:10.1007/pl00005057. PMID 9303568. 
  3. "Pharmacological diversity between native human 5-HT1B and 5-HT1D receptors sited on different neurons and involved in different functions". British Journal of Pharmacology 126 (3): 607–12. February 1999. doi:10.1038/sj.bjp.0702336. PMID 10188970. 
  4. "Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input". Neuroscience 122 (2): 491–8. 2003. doi:10.1016/s0306-4522(03)00570-0. PMID 14614913.